How Cancer treatment Works

Surgery remains the oldest and most straightforward cancer treatment: a surgeon cuts out the tumor and surrounding tissue during an operation. For solid tumors like breast cancer or colon cancer, surgery works best when the cancer is localized and hasn't spread to distant organs. The surgeon aims to remove the entire tumor plus a margin of healthy tissue to ensure no cancer cells remain at the edges.

The success of surgical removal depends heavily on the tumor's location and accessibility. A tumor on the skin or in an easily accessible organ like the breast can often be completely excised, while cancers in the brain or wrapped around major blood vessels pose significant challenges. Surgeons use imaging technology like MRI and CT scans to map the tumor's boundaries before cutting, and sometimes examine tissue samples during the operation to verify they've removed all cancerous cells.

Modern surgical techniques have become increasingly precise, with some procedures using robotic assistance or minimally invasive approaches through small incisions. However, surgery cannot address cancer cells that have already broken away and traveled to other parts of the body—these microscopic metastases are invisible to the surgeon's eye. This is why surgery is often combined with other treatments to destroy any remaining cancer cells.

Chemotherapy works by poisoning cells that divide frequently, which is cancer's defining characteristic. These drugs circulate through the bloodstream and reach cancer cells wherever they hide in the body, making chemotherapy essential for treating cancers that have spread or might have spread. Different chemotherapy drugs attack dividing cells through various methods: some damage DNA directly, others prevent cells from copying their genetic material, and some interfere with the cell division machinery itself.

The fundamental problem with chemotherapy is that it cannot perfectly distinguish cancer cells from healthy cells that also divide rapidly. Hair follicles, the cells lining the digestive tract, and bone marrow cells all divide frequently as part of their normal function, which explains chemotherapy's notorious side effects: hair loss, nausea, and weakened immune systems. Oncologists carefully calibrate dosages to kill cancer cells while keeping damage to healthy tissues within tolerable limits.

Chemotherapy is typically administered in cycles—periods of treatment followed by rest periods that allow healthy cells to recover while cancer cells continue dying. Some cancers respond dramatically to chemotherapy, shrinking or disappearing entirely, while others prove resistant. The effectiveness depends on the specific cancer type and its genetic makeup, which is why doctors often test tumors to predict which chemotherapy drugs will work best.

Radiation therapy uses high-energy X-rays, gamma rays, or particle beams to break the DNA strands inside cancer cells. When DNA sustains enough damage, the cell can no longer divide and eventually dies. Unlike chemotherapy's whole-body approach, radiation can be aimed with remarkable precision at specific tumors, sparing most healthy tissue from exposure.

Modern radiation machines can shape beams to match a tumor's exact three-dimensional contour, delivering maximum dose to the cancer while minimizing exposure to surrounding organs. Radiation oncologists use CT scans and other imaging to map the tumor's location, then calculate the optimal angles and intensities for the beams. Some techniques deliver radiation from hundreds of different angles, with each individual beam too weak to cause much damage but all converging on the tumor to create a lethal dose at that precise spot.

Radiation therapy exploits a crucial difference between cancer cells and healthy cells: healthy cells generally repair DNA damage more effectively. By fractionating treatment—delivering smaller doses over many sessions rather than one massive dose—doctors give healthy cells time to fix the damage between sessions while cancer cells accumulate irreparable harm. Some cancers are exquisitely sensitive to radiation and can be cured with radiation alone, while others require radiation as part of a combination strategy.

Cancer cells normally evade the immune system through various disguises and suppression tactics, essentially hiding in plain sight among healthy tissues. Immunotherapy removes these disguises or supercharges immune cells so they recognize and attack cancer. Some immunotherapy drugs called checkpoint inhibitors work by blocking the "off switches" that cancer cells use to deactivate immune T-cells, allowing these killer cells to do their job.

Other immunotherapy approaches involve removing a patient's T-cells, genetically engineering them in the laboratory to recognize specific proteins on cancer cells, then infusing billions of these modified cells back into the patient. These CAR-T cells act like guided missiles, hunting down cancer cells throughout the body. The technique has produced remarkable results in certain blood cancers, with some patients achieving complete remission after all other treatments failed.

The challenge with immunotherapy is predicting who will respond—some patients experience dramatic tumor shrinkage while others see no benefit at all. The immune system's power cuts both ways: when it attacks cancer aggressively, it can also attack healthy tissues, causing inflammatory side effects in the lungs, intestines, or other organs. Researchers are working to identify biomarkers that predict response and to combine immunotherapy with other treatments to improve success rates across different cancer types.

Targeted therapy exploits specific genetic mutations and molecular abnormalities that drive individual cancers. Unlike chemotherapy's blunt approach of poisoning all dividing cells, targeted drugs are designed to interfere with particular proteins or signaling pathways that cancer cells depend on for survival. For example, some breast cancers overexpress a protein called HER2 that promotes aggressive growth; drugs like trastuzumab specifically block this protein, starving those cancer cells of their growth signal.

Many targeted therapies work by blocking the receptors or enzymes involved in cancer cell growth pathways. Cancer cells often have mutations that keep growth signals permanently "on," like a stuck accelerator pedal driving uncontrolled division. Targeted drugs act like molecular wrenches thrown into this machinery, binding to these mutated proteins and preventing them from functioning. Some drugs block blood vessel formation around tumors, cutting off the oxygen and nutrients the cancer needs to expand.

The precision of targeted therapy means fewer side effects than traditional chemotherapy, since healthy cells without these specific mutations are largely unaffected. However, targeted therapy only works when a cancer has the specific molecular target the drug is designed to attack, which is why genetic testing of tumors has become crucial. Cancer cells can also develop resistance over time by finding alternative growth pathways or mutating the target itself, which is why doctors often combine multiple targeted drugs or rotate between different agents.